These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 11161620
1. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment. Harrison MB, Kumar S, Hubbard CA, Trugman JM. Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620 [Abstract] [Full Text] [Related]
2. 3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum. Adams DH, Hanson GR, Keefe KA. Brain Res Mol Brain Res; 2005 Jan 05; 133(1):131-42. PubMed ID: 15661373 [Abstract] [Full Text] [Related]
3. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat. Mijnster MJ, Schotte A, Docter GJ, Voorn P. Synapse; 1998 Apr 05; 28(4):302-12. PubMed ID: 9517839 [Abstract] [Full Text] [Related]
4. Effect of apomorphine on striatal synaptotagmin 7 mRNA levels in reserpinized rats. Pal R, Zivin M, Milutinovic A, Jernej B, Glavan G. Neurosci Lett; 2007 Sep 13; 424(3):194-8. PubMed ID: 17719177 [Abstract] [Full Text] [Related]
5. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Le Foll B, Diaz J, Sokoloff P. Synapse; 2003 Mar 13; 47(3):176-83. PubMed ID: 12494400 [Abstract] [Full Text] [Related]
6. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE. Synapse; 1994 Nov 13; 18(3):178-89. PubMed ID: 7531873 [Abstract] [Full Text] [Related]
7. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Van De Witte SV, Groenewegen HJ, Voorn P. Synapse; 2002 Jan 13; 43(1):1-11. PubMed ID: 11746728 [Abstract] [Full Text] [Related]
8. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery. Zeng BY, Jenner P, Marsden CD. Mov Disord; 1996 Jan 13; 11(1):43-52. PubMed ID: 8771066 [Abstract] [Full Text] [Related]
9. Enhancement of the behavioral response to apomorphine administration following repeated treatment in the 6-hydroxydopamine-lesioned rat is temporally correlated with a rise in striatal preproenkephalin-B, but not preproenkephalin-A, gene expression. Duty S, Brotchie JM. Exp Neurol; 1997 Apr 13; 144(2):423-32. PubMed ID: 9168843 [Abstract] [Full Text] [Related]
10. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Shi X, McGinty JF. Neuroscience; 2006 Apr 13; 138(4):1289-98. PubMed ID: 16459022 [Abstract] [Full Text] [Related]
11. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Harrison LM, LaHoste GJ. Neuroscience; 2006 Apr 13; 137(2):483-92. PubMed ID: 16352400 [Abstract] [Full Text] [Related]
12. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Cenci MA, Lee CS, Björklund A. Eur J Neurosci; 1998 Aug 13; 10(8):2694-706. PubMed ID: 9767399 [Abstract] [Full Text] [Related]
13. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Ann Neurol; 1995 Dec 13; 38(6):852-61. PubMed ID: 8526457 [Abstract] [Full Text] [Related]
14. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. Aubert I, Ghorayeb I, Normand E, Bloch B. J Comp Neurol; 2000 Feb 28; 418(1):22-32. PubMed ID: 10701753 [Abstract] [Full Text] [Related]
15. Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats. Haberny SL, Carr KD. Brain Res Mol Brain Res; 2005 Nov 30; 141(2):121-7. PubMed ID: 16257473 [Abstract] [Full Text] [Related]
16. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E, Krysiak R, Wieronska JM, Smialowska M, Herman ZS. Neuropeptides; 2005 Oct 30; 39(5):515-23. PubMed ID: 16154634 [Abstract] [Full Text] [Related]
17. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. Carta AR, Tronci E, Pinna A, Morelli M. Eur J Neurosci; 2005 Mar 30; 21(5):1196-204. PubMed ID: 15813929 [Abstract] [Full Text] [Related]
18. Imipramine induces alterations in proenkephalin and prodynorphin mRNAs level in the nucleus accumbens and striatum in the rat. Przewłocki R, Lasoń W, Turchan J, Przewłocka B. Pol J Pharmacol; 1997 Mar 30; 49(5):351-5. PubMed ID: 9566035 [Abstract] [Full Text] [Related]
20. Altered expression of preproenkephalin and prodynorphin mRNA in a genetic model of paroxysmal dystonia. Nobrega JN, Parkes JH, Wong P, Raymond R, Richter A. Brain Res; 2004 Jul 23; 1015(1-2):87-95. PubMed ID: 15223370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]